Lupin logo

Lupin Q1 results, quarter to Jun 2026

NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap

Lupin Limited · Face value ₹2 · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹2,011.00up ₹21.10 (1.06%)BSE ₹2,009.00

Share price at the NSE close on 30 Oct 2026. Previous close ₹1,989.90.

30 Oct: open ₹1,995.70, high ₹2,021.80, low ₹1,974.00

52-week range of traded prices to 30 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
Market cap
₹91,961 Cr105th largest listed
P/E
16.63
P/E without one-offs
15.11
P/B
4.10
Dividend yield
0.90%
ROE
27.9%
ROE without one-offs
30.7%
ROCE
28.2%
Debt to equity
0.26
Volume, NSE
7,59,66358.6% delivered

Lupin filed its Q1 results for the quarter to Jun 2026 on 6 Aug 2026 at 10:25 pm, consolidated: the company and its subsidiaries together.

Q1 results, quarter to Jun 2026

₹ crore.Lupin annual results and balance sheet

Revenue
₹8,277 Cr+32.0% on a year ago · +10.7% on the quarter before
Operating profit
₹2,450 Cr+41.8% on a year ago · −1.4% on the quarter before
Net profit
₹1,417 Cr+16.0% on a year ago · −3.5% on the quarter before
Earnings per share
₹30.95+15.9% on a year ago · −3.2% on the quarter before
Operating margin
29.6%
Net margin
17.1%

From revenue to net profit, ₹ crore

  1. Revenue8,277
  2. Materials and goods−2,089
  3. Employee costs−1,383
  4. Other expenses−2,355
  5. Operating profit2,450
  6. Depreciation−453
  7. Other income+130
  8. Finance costs−110
  9. Profit before tax2,017
  10. Tax−600
  11. Joint ventures0.0
  12. Net profit1,417

Lupin results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
5,039495Sep 235,197619Dec 234,961368Mar 245,600806Jun 245,673859Sep 245,768859Dec 245,667782Mar 256,2681,221Jun 257,0481,485Sep 257,1681,181Dec 257,4751,469Mar 268,2771,417Jun 26
Peak revenue ₹8,277 Cr, quarter to Jun 2026; lowest ₹4,961 Cr, quarter to Mar 2024

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
33.3%7.4%18.2%20.0%20.1%22.2%23.6%23.5%23.3%27.6%33.2%31.6%33.3%29.6%9.8%11.9%7.4%14.4%15.2%14.9%13.8%19.5%21.1%16.5%19.6%17.1%Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Jun 26
₹ croreSep 2021Dec 2021Q3Mar 2022Jun 2022Q1Sep 2022Dec 2022Q3Mar 2023Jun 2023Q1Filed 3 AugSep 2023Dec 2023Q3Mar 2024Jun 2024Q1Sep 2024Dec 2024Q3Filed 12 FebMar 2025Q4Jun 2025Q1Filed 5 AugSep 2025Q2Filed 6 NovDec 2025Q3Filed 12 FebMar 2026Q4Filed 7 MayJun 2026Q1Filed 6 Aug
Revenue from operations4,0914,1613,8833,7444,1464,3224,4304,8145,0395,1974,9615,6005,6735,7685,6676,2687,0487,1687,4758,277
5,4153,7913,6153,5123,6933,7903,8523,9584,1214,1593,9644,3594,3324,4124,3464,5414,7064,9064,9895,827
Materials and goods bought1,6261,6951,6321,6101,7131,7071,7501,6411,7031,7261,5741,7451,6901,7221,6861,7721,8251,8781,8522,089
Employee costs7597447037797727647738448618899009711,0089841,0011,0831,1061,1431,2431,383
Other expenses3,0301,3531,2801,1231,2081,3181,3291,4731,5571,5441,4901,6441,6351,7061,6591,6861,7761,8841,8952,355
Operating profit before depreciation−1,3243702682324535335788569181,0389971,2411,3401,3561,3211,7272,3412,2622,4862,450
Operating margin−32.4%8.9%6.9%6.2%10.9%12.3%13.0%17.8%18.2%20.0%20.1%22.2%23.6%23.5%23.3%27.6%33.2%31.6%33.3%29.6%
Depreciation and amortisation919203327193203220264235248257457248257271393299317313447453
Other income733416615183723402929684254577990115141130
Finance costs34334143558493868174716871678992108115120110
Profit before one-off items and tax−2,205167−8522102462595596307364989931,0551,0718961,4162,0071,9492,0592,017
One-off items00000000000000000−427−1310
Profit before tax−2,205167−8522102462595596307364989931,0551,0718961,4162,0071,5221,9282,017
−110−38242789758816105134117129187195212113194522342459600
Tax rate–−228.7%–3,924.7%35.8%36.0%6.2%18.9%21.3%15.9%26.0%18.9%18.5%19.8%12.7%13.7%26.0%22.4%23.8%29.8%
Share of profit of joint ventures and associates000––––––––––––––––0
−2,095549−512−871341582424534956193688068598597821,2211,4851,1811,4691,417
Other comprehensive income−117−38173−86−8618312−362278−27−5358−12023160961206436
Total comprehensive income−2,212511−338−173493412554185186973417539177398051,3821,5811,3011,5331,452
Net margin−51.2%13.2%−13.2%−2.3%3.2%3.6%5.5%9.4%9.8%11.9%7.4%14.4%15.2%14.9%13.8%19.5%21.1%16.5%19.6%17.1%
Net margin without joint ventures and associates−51.2%13.2%−13.2%––––––––––––––––17.1%
Earnings per share−₹46.22₹12.01−₹11.40–₹2.85₹3.38₹5.19₹9.94₹10.76₹13.47₹7.89₹17.58₹18.70₹18.75₹16.93₹26.70₹32.36₹25.74₹31.96₹30.95
Diluted earnings per share−₹46.22₹11.98−₹11.40–₹2.85₹3.36₹5.16₹9.90₹10.72₹13.41₹7.86₹17.52₹18.64₹18.69₹16.87₹26.62₹32.28₹25.67₹31.89₹30.89
Earnings per share in rupees, restated for later splits and bonuses.

Segment results by quarter

Consolidated, ₹ crore, quarters to Jun 2026.Lupin segment results by year

  • Pharmaceuticals

    Revenue, ₹ crore
    Profit, ₹ crore
  • Others

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue of all businesses5,0395,1984,9625,6005,6735,7685,6686,2697,0487,1687,4758,277
Company revenue, as in its results5,0395,1974,9615,6005,6735,7685,6676,2687,0487,1687,4758,277
Revenue5,0215,1804,9425,5795,6475,7425,6366,2367,0107,1317,4358,234
Revenue growth––––12.5%10.9%14.1%11.8%24.1%24.2%31.9%32.0%
Profit6597675341,0311,0891,1089321,4582,0481,5671,9772,061
Profit growth––––65.3%44.5%74.5%41.4%88.1%41.4%112.1%41.3%
Margin13.1%14.8%10.8%18.5%19.3%19.3%16.5%23.4%29.2%22.0%26.6%25.0%
Assets23,443–24,044–25,540–29,28331,89133,24734,97538,12940,603
Liabilities10,070–9,612–9,678–11,82112,98513,67514,09515,74616,738
Capital employed13,374–14,432–15,862–17,46218,90619,57320,88022,38223,865
Revenue181820212626323238374043
––––––––00–0
––––0–00––0–
––––0–00––0–
Profit is before tax and finance costs, the way companies report their segments.